Finch Therapeutics Group, Inc.·4

Feb 28, 6:48 PM ET

Vittiglio Joseph 4

4 · Finch Therapeutics Group, Inc. · Filed Feb 28, 2022

Insider Transaction Report

Form 4
Period: 2022-02-25
Vittiglio Joseph
Chief Business & Legal Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-02-25+75,00075,000 total
    Exercise: $8.61Exp: 2032-02-24Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]This option vests in equal monthly installments over a four-year period commencing on February 1, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION